ID   Hs 789.T
AC   CVCL_0908
SY   Hs789T
DR   CLO; CLO_0004115
DR   ATCC; CRL-7886
DR   BioSample; SAMN03471110
DR   Wikidata; Q54896041
RX   PubMed=176412;
RX   PubMed=29732388;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 12-14 days (PubMed=176412).
ST   Source(s): ATCC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,11,13
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C39851; Bladder urothelial carcinoma
DI   ORDO; Orphanet_209989; Non-papillary transitional cell carcinoma of the bladder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0907 ! Hs 789.Sk
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
RX   PubMed=176412; DOI=10.1093/jnci/56.4.843;
RA   Owens R.B., Smith H.S., Nelson-Rees W.A., Springer E.L.;
RT   "Epithelial cell cultures from normal and cancerous human tissues.";
RL   J. Natl. Cancer Inst. 56:843-849(1976).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167;
RA   Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.;
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//